Skip to content

L2Be Pharma

Active Private limited companyfounded 2021active for 5 yearsRue Saint-Paul 47, 7130 BincheKBO/BCE: BE 0764.501.936

Annual accounts 2025

micro format, filed on 23-06-2026, 38 days before the deadline
€36,781
▲ 13.0%
€21,342
▼ 32.5%
€14,987
▼ 32.1%
€57,221
unchanged
37.3%
▼ 1.4 percentage points
1.59
▼ 0.04

Turnover is estimated at about €150,000, probably between €87,000 and €260,000. The micro format does not state turnover.

Balance sheet

balance sheet total €153,570 on 31-12-2025
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

37.3%

Higher than 40% of the 4,579 companies filing micro accounts in other professional activities (NACE 74) in 2025.

1.59

Higher than 43% of the 4,394 companies filing micro accounts in other professional activities (NACE 74) in 2025.

9.8%

Higher than 50% of the 4,429 companies filing micro accounts in other professional activities (NACE 74) in 2025.

L2Be Pharma Middle half of the sector 80% of the sector Micro accounts in other professional activities (NACE 74)

Net result: middle half · Equity: middle half · Balance sheet total: middle half · Working capital: middle half

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend2025202420232022202110 months
-31,79557,27111,27667,490
-22,22443,3206,01748,014
-001732,394
22,38510,26327,78413,408-
57,22157,22199,95956,63750,620
37.3%38.7%71.3%61.7%59.7%
1.591.633.492.592.45
1.681.590.400.620.67
26.2%38.6%42.8%9.5%90.3%
9.8%14.9%30.6%5.8%54.0%
-14.5525.044.7974.96

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend2025202420232022202110 months
Balance sheet: assets
20/58 153,570147,948140,34092,74186,700
20 ----173
21/28 --1615841,007
22/27 --1615841,007
24 --1615841,007
29/58 153,570147,948140,17992,15785,521
40/41 28,62233,43240,26229,23131,605
40 21,59933,43240,26229,23131,605
41 7,023----
54/58 123,358100,97390,71062,92649,518
490/1 1,59013,5449,207-4,398
Balance sheet: equity and liabilities
10/49 153,570147,948140,34092,74186,700
10/15 57,22157,221100,11757,22151,799
10/11 5,0005,0005,0005,0005,000
13 52,22152,22195,11752,22146,799
133 52,22152,22195,11752,22146,799
17/49 96,34990,72840,22335,52034,901
42/48 96,34990,72840,22035,52034,901
44 4,0164,4658,7845,2796,749
440/4 4,0164,4658,7845,2796,749
45 20,72029,07529,63830,00927,879
450/3 17,42025,77526,33826,70924,879
454/9 3,3003,3003,3003,3003,000
47/48 71,61457,1881,798233272
492/3 --3--
Income statement
9900 36,78132,55057,43611,67067,586
630 -1614235951,214
640/8 15,43975416539596
9901 21,34231,63456,84810,68066,275
75/76B 839-31-
75 839-31-
65/66B 2,2922,1862,2872,352900
65 2,2922,1862,2872,352900
9903 19,88929,44854,5648,32965,375
67/77 4,9027,38611,6682,90718,576
9904 14,98722,06342,8975,42146,799
9905 14,98722,06342,8975,42146,799
Appropriation of the result
9906 14,98722,06342,8975,42146,799
791/2 -42,897---
691/2 --42,8975,42146,799
6921 --42,8975,42146,799
794 -335---
694/7 14,98765,294---
694 14,98765,294---
Document PDFPDFPDFPDFPDF

The full notes are in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 23-06-2026.

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
31-12-2025 micro format 23-06-2026 2026-00186459 PDF
31-12-2024 micro format 06-08-2025 2025-00366548 PDF
31-12-2023 micro format 05-07-2024 2024-00220436 PDF
31-12-2022 micro format 29-08-2023 2023-00376440 PDF
31-12-2021 micro format 24-08-2022 2022-20315981 PDF

Investments

fixed assets acquired
Item20252024202320222021
Tangible fixed assets----€2,394
-€161€423€595€1,214

Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)

Insights on L2Be Pharma

The operating result for 2025 is 33% lower than in 2024 and the lowest since 2022. It is the second fall in a row.

Debt's share of the balance-sheet total rises from 61.3% to 62.7%. Debt is higher.

Next steps